Dr. Alex Rogers Minter, MD

Dr. Minter practices at Russell Medical in Alexander City, Alabama, part of University of Alabama at Birmingham.

Dr. Minter's NPI, 1265588230, was assigned on January 25, 2007. Dr. Minter graduated from Heersink School of Medicine - Birmingham in 2001. Dr. Minter's Alabama license number on file is 25054.

Dr. Minter's primary practice is Russell Medical, at 3316 Highway 280, Alexander City, AL 35010 in Tallapoosa County. The practice phone is (256) 329-7100.

Dr. Minter's primary practice is Russell Medical in Alexander City, Alabama, part of University of Alabama at Birmingham. Dr. Minter is also affiliated with East Alabama Medical Center. The medical group on file is Russell Medical.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Minter practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Minter's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Minter is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Minter's licenses on file in 2 states: Alabama and Montana.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Minter treats.

CMS data shows 710 Medicare services from Dr. Minter across 6 procedure codes in 2024, for 219 Medicare patients. Medicare paid $30,038 for them.

CMS counts 219 Medicare patients who saw Dr. Minter in 2024. The largest group is 75 to 84, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Minter's median patient age at 72, with 52% women.

In 2024, Dr. Minter wrote 1,191 Medicare Part D claims for 160 patients. 83% of them were for generic drugs. CMS names the drug for 990 of them, across 32 drugs with 11 or more claims each, at $2,160,036 in total drug cost. In 2023, CMS named 981 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Minter for performance year 2024, reported as part of a group. Dr. Minter accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Minter, published from 2011 to 2021. The most frequent topics are Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. Dr. Minter's most frequent co-authors are Neha Korde, MD, Laura Quillian Rogers and Karen Kurdziel, MD.

CMS Open Payments shows 150 general payments to Dr. Minter from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $329.

Dr. Minter graduated from Heersink School of Medicine - Birmingham in 2001.

Dr. Minter is in network with 15 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.